Literature DB >> 9218455

The influence of antisense oligonucleotide-induced RNA structure on Escherichia coli RNase H1 activity.

W F Lima1, V Mohan, S T Crooke.   

Abstract

The ability of Escherichia coli RNase H1 to hydrolyze structured substrates containing antisense oligonucleotides preannealed to a 47-mer RNA was compared with its ability to hydrolyze unstructured substrates containing antisense oligonucleotides duplexed with 13-mer RNA. These results demonstrate that when antisense oligonucleotides were bound to structured RNA, the resultant duplexes were cleaved at rates significantly slower than when the same oligonucleotides were bound to unstructured oligoribonucleotides. Structured substrates exhibited fewer cleavage sites, and each cleavage site was cleaved less rapidly than in unstructured substrates. Furthermore, the enzymatic activity of E. coli RNase H1 for the structured substrates was most affected when the cleavage sites corresponding to the enzymatically most active sites on the unstructured substrates were blocked in the structured substrates. Molecular modeling suggests that the observed ablation of RNase H activity was due to the steric hindrance of the enzyme by the structured RNA, i.e. steric interference of the phosphate groups on the substrate and/or the binding site of the enzyme. When chimeric oligonucleotides composed of a five-base deoxynucleotide sequence flanked by chemically modified nucleotides were bound to structured RNA, the resultant duplexes were even worse substrates for RNase H. These results offer further insights into the role of antisense-induced RNA structure on RNase H activity and may facilitate the design of effective antisense oligonucleotides.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9218455     DOI: 10.1074/jbc.272.29.18191

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Crystallization and preliminary X-ray analysis of Escherichia coli RNase HI-dsRNA complexes.

Authors:  Lioudmila V Loukachevitch; Martin Egli
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-01-17

2.  RNase H mediated cleavage of RNA by cyclohexene nucleic acid (CeNA).

Authors:  B Verbeure; E Lescrinier; J Wang; P Herdewijn
Journal:  Nucleic Acids Res       Date:  2001-12-15       Impact factor: 16.971

3.  Mapping of accessible sites for oligonucleotide hybridization on hepatitis delta virus ribozymes.

Authors:  J Wrzesinski; M Legiewicz; J Ciesiołka
Journal:  Nucleic Acids Res       Date:  2000-04-15       Impact factor: 16.971

4.  The effect of structure in a long target RNA on ribozyme cleavage efficiency.

Authors:  T B Campbell; C K McDonald; M Hagen
Journal:  Nucleic Acids Res       Date:  1997-12-15       Impact factor: 16.971

5.  Fatty Acid-Modified Gapmer Antisense Oligonucleotide and Serum Albumin Constructs for Pharmacokinetic Modulation.

Authors:  Michael Lykke Hvam; Yunpeng Cai; Frederik Dagnæs-Hansen; Jesper Sejrup Nielsen; Jesper Wengel; Jørgen Kjems; Kenneth A Howard
Journal:  Mol Ther       Date:  2017-06-20       Impact factor: 11.454

Review 6.  Crystallographic studies of chemically modified nucleic acids: a backward glance.

Authors:  Martin Egli; Pradeep S Pallan
Journal:  Chem Biodivers       Date:  2010-01       Impact factor: 2.408

7.  Biochemical properties of phosphonoacetate and thiophosphonoacetate oligodeoxyribonucleotides.

Authors:  David Sheehan; Benjamin Lunstad; Christina M Yamada; Brian G Stell; Marvin H Caruthers; Douglas J Dellinger
Journal:  Nucleic Acids Res       Date:  2003-07-15       Impact factor: 16.971

8.  Insights into RNA/DNA hybrid recognition and processing by RNase H from the crystal structure of a non-specific enzyme-dsDNA complex.

Authors:  Pradeep S Pallan; Martin Egli
Journal:  Cell Cycle       Date:  2008-08-18       Impact factor: 4.534

9.  DNAzyme-mediated recovery of small recombinant RNAs from a 5S rRNA-derived chimera expressed in Escherichia coli.

Authors:  Yamei Liu; Victor G Stepanov; Ulrich Strych; Richard C Willson; George W Jackson; George E Fox
Journal:  BMC Biotechnol       Date:  2010-12-06       Impact factor: 2.563

10.  Allele-specific suppression of mutant huntingtin using antisense oligonucleotides: providing a therapeutic option for all Huntington disease patients.

Authors:  Niels H Skotte; Amber L Southwell; Michael E Østergaard; Jeffrey B Carroll; Simon C Warby; Crystal N Doty; Eugenia Petoukhov; Kuljeet Vaid; Holly Kordasiewicz; Andrew T Watt; Susan M Freier; Gene Hung; Punit P Seth; C Frank Bennett; Eric E Swayze; Michael R Hayden
Journal:  PLoS One       Date:  2014-09-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.